Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Debt Ratio: 2016-2017

Historic Debt Ratio for Corcept Therapeutics (CORT) over the last 1 years, with Jun 2017 value amounting to 0.05.

  • Corcept Therapeutics' Debt Ratio fell 86.53% to 0.05 in Q2 2017 from the same period last year, while for Jun 2017 it was 0.05, marking a year-over-year decrease of 86.53%. This contributed to the annual value of 0.21 for FY2016, which is N/A change from last year.
  • According to the latest figures from Q2 2017, Corcept Therapeutics' Debt Ratio is 0.05, which was down 60.61% from 0.13 recorded in Q1 2017.
  • In the past 5 years, Corcept Therapeutics' Debt Ratio ranged from a high of 0.47 in Q1 2016 and a low of 0.05 during Q2 2017.
  • Over the past 2 years, Corcept Therapeutics' median Debt Ratio value was 0.26 (recorded in 2016), while the average stood at 0.26.
  • Data for Corcept Therapeutics' Debt Ratio shows a maximum YoY slumped of 86.53% (in 2017) over the last 5 years.
  • Corcept Therapeutics' Debt Ratio (Quarterly) stood at 0.21 in 2016, then crashed by 86.53% to 0.05 in 2017.
  • Its Debt Ratio was 0.05 in Q2 2017, compared to 0.13 in Q1 2017 and 0.21 in Q4 2016.